The 3rd Annual Biosimilars Market Access Summit 2017 covers topics such as:
- Current market dynamics for biosimilar uptake in the U.S
- The latest FDA guidances and thinking
- Various pricing strategies and other market access approaches
- Payer and provider considerations for market entry
- Ways to encourage physician and patient acceptance of biosimilars
The 3rd Annual Biosimilars Market Access Summit 2017 brings together senior managers of:
- Market Access
- Biosimilars
- Commercial Operations
- Commercial Strategy
- Channel Strategy
- Pricing and Reimbursement
- Strategic Partnerships
- Regulatory Affairs
